Sarepta Therapeutics (NASDAQ:SRPT) Hits New 12-Month Low Following Analyst Downgrade
Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) hit a new 52-week low on Monday after Deutsche Bank Aktiengesellschaft lowered their price target on the stock from $50.00 to $25.00. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock. Sarepta Therapeutics traded as low as $18.66 and last traded at $18.84, […]
Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) hit a new 52-week low on Monday after Deutsche Bank Aktiengesellschaft lowered their price target on the stock from $50.00 to $25.00. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock. Sarepta Therapeutics traded as low as $18.66 and last traded at $18.84, […]
